Zoetis Inc. current report, 12 May 2016

Full document

Zoetis Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K covers events occurring on May 12, 2016, the date of Zoetis Inc.'s Annual Meeting of Shareholders. The meeting was held at the Hilton Short Hills in New Jersey. A quorum was established with 435,887,451 shares present, representing 87.8% of the voting power.

Key Financial Metrics

This filing does not contain comprehensive financial statements, revenue, profit, or cash flow data. The only financial metric disclosed is a dividend declaration:

  • Dividend Declared: $0.095 per share for the third quarter of 2016.
  • Record Date: June 30, 2016.
  • Payment Date: August 30, 2016.

Material Changes and Corporate Actions

The filing details the results of three shareholder proposals and a new board committee formation:

  1. Election of Directors: All four nominees (Juan Ramón Alaix, Paul M. Bisaro, Frank A. D'Amelio, and Michael B. McCallister) were elected to serve until the 2019 Annual Meeting.
  2. Executive Compensation: Shareholders approved a non-binding advisory vote on the compensation program for named executive officers.
  3. Independent Auditor: Shareholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2016.
  4. New Board Committee: The Board established a "Quality and Innovation Committee" to oversee manufacturing quality, environmental/health/safety matters, R&D strategies, and innovation. The committee is chaired by Paul M. Bisaro and includes Sanjay Khosla and Willie M. Reed.

Guidance, Outlook, and Risks

This filing does not provide forward-looking guidance, management commentary on financial outlook, or specific risk factors. It is a procedural report regarding shareholder voting results and corporate governance updates.

Investor Verification Checklist

  • Verify the dividend payment date (August 30, 2016) and record date (June 30, 2016) for the $0.095 per share distribution.
  • Confirm the composition of the new Quality and Innovation Committee and its specific oversight mandates.
  • Review the definitive proxy statement filed on April 1, 2016, for detailed information on the executive compensation program that was approved.
  • Note that the filing does not contain updated financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.